对人类癌症的大规模表观基因组分析揭示了乳腺癌中影响SMC5/6复杂元件的频繁变化
Shamayita Roy1, Arvin Zaker2, Arvind Mer2
1Ottawa Institute of Systems Biology, Department of Cellular and Molecular Medicine, University of Ottawa, Roger Guindon Hall, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.
NAR cancer
|September 14, 2023
概括
染色体结构的关键调节者SMC5/6复合物的突变在乳腺癌中很常见. 这些遗传变化破坏了基因组的稳定性,并影响了患者的存活率,强调SMC5/6是癌症发展的关键因素.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 分子遗传学 分子遗传学
背景情况:
- 由于DNA损伤和复制压力,癌细胞表现出基因组不稳定性.
- 核心染色体结构调节者的突变,如SMC5/6复合体,在癌症发展中的作用仍然不清楚.
研究的目的:
- 在多种癌症基因组学队伍中系统分析SMC5/6复合体中的突变.
- 研究SMC5/6突变与癌症表型之间的关联,包括基因组稳定性和患者存活率.
主要方法:
- 分析了来自144种组织类型和199种癌症基因组研究的64,959个癌症样本.
- 对针对SMC5/6复合体的患者衍生突变的检查.
- 对表型结果的评估,如 ploidy 控制和整体存活率.
主要成果:
- 在乳腺癌患者中,SMC5/6复合体经常发生变化.
- 在SMC5/6复合体中发生的突变与失去虫控制和降低整体存活率相关.
- 一些SMC5/6突变的表型效应甚至在异合状态下也很明显.
结论:
- 复杂的SMC5/6变化是乳腺癌发病的重要贡献者.
- 调节染色体结构的基因,如SMC5/6,在人类癌症发育中起着关键作用.
- SMC5/6突变代表了理解和治疗癌症的潜在目标.
更多相关视频
06:24Multiplexed Analysis of Retinal Gene Expression and Chromatin Accessibility Using scRNA-Seq and scATAC-Seq
Published on: March 12, 2021
3.6K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.5K
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
